Abstract LB-145: Results of a phase I study of AZD4547, an inhibitor of fibroblast growth factor receptor (FGFR), in patients with advanced solid tumors .
2014 ◽
Vol 32
(15_suppl)
◽
pp. 11010-11010
◽
2012 ◽
Vol 48
◽
pp. 191-192
◽
2019 ◽
Vol 25
(16)
◽
pp. 4888-4897
◽
2017 ◽
Vol 35
(4)
◽
pp. 451-462
◽
2017 ◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 2501-2501
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 2545-2545
◽